null

SMILES: COC[C@@H]1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1P(C)(C)=O

InChI Key: InChIKey=IXBXSESPQWWNHZ-HRAATJIYSA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 450267   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450267 (US10676431, Example 30 | US11117861, Example 30) Show SMILES COC[C@@H]1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1P(C)(C)=O |r| Show InChI InChI=1S/C27H26ClF3N3O4P/c1-38-14-16-13-21(33-27(36)32-20-10-8-15(28)12-19(20)29)26(35)34(16)22-11-9-18(24(30)25(22)31)17-6-4-5-7-23(17)39(2,3)37/h4-12,16,21H,13-14H2,1-3H3,(H2,32,33,36)/t16-,21+/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.220	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450267 (US10676431, Example 30 | US11117861, Example 30) Show SMILES COC[C@@H]1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1P(C)(C)=O |r| Show InChI InChI=1S/C27H26ClF3N3O4P/c1-38-14-16-13-21(33-27(36)32-20-10-8-15(28)12-19(20)29)26(35)34(16)22-11-9-18(24(30)25(22)31)17-6-4-5-7-23(17)39(2,3)37/h4-12,16,21H,13-14H2,1-3H3,(H2,32,33,36)/t16-,21+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	83	n/a	n/a	n/a	n/a
TBA					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				Citation and Details BindingDB Entry DOI: 10.7270/Q2ZK5KV9
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM450267 (US10676431, Example 30 | US11117861, Example 30) Show SMILES COC[C@@H]1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1P(C)(C)=O |r| Show InChI InChI=1S/C27H26ClF3N3O4P/c1-38-14-16-13-21(33-27(36)32-20-10-8-15(28)12-19(20)29)26(35)34(16)22-11-9-18(24(30)25(22)31)17-6-4-5-7-23(17)39(2,3)37/h4-12,16,21H,13-14H2,1-3H3,(H2,32,33,36)/t16-,21+/m0/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.220	n/a	n/a	n/a	n/a
TBA					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				Citation and Details BindingDB Entry DOI: 10.7270/Q2ZK5KV9
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM450267 (US10676431, Example 30 | US11117861, Example 30) Show SMILES COC[C@@H]1C[C@@H](NC(=O)Nc2ccc(Cl)cc2F)C(=O)N1c1ccc(c(F)c1F)-c1ccccc1P(C)(C)=O |r| Show InChI InChI=1S/C27H26ClF3N3O4P/c1-38-14-16-13-21(33-27(36)32-20-10-8-15(28)12-19(20)29)26(35)34(16)22-11-9-18(24(30)25(22)31)17-6-4-5-7-23(17)39(2,3)37/h4-12,16,21H,13-14H2,1-3H3,(H2,32,33,36)/t16-,21+/m0/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	83	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (200 μM final) were added to 384-well Proxiplates (Perki...				US Patent US10676431 (2020) BindingDB Entry DOI: 10.7270/Q2N58QFS
					More data for this Ligand-Target Pair